Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 25, 2017

DrugPatentWatch Database Preview

Iopamidol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for iopamidol and what is the scope of freedom to operate?

Iopamidol
is the generic ingredient in eighteen branded drugs marketed by Hospira, Bracco, Baxter Hlthcare, Abbvie, Fresenius Kabi Usa, Cook Imaging, and Sanochemia Corp Usa, and is included in twelve NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for iopamidol. Two suppliers are listed for this compound.

Summary for Generic Name: iopamidol

Tradenames:18
Patents:1
Applicants:7
NDAs:12
Drug Master File Entries: see list11
Suppliers / Packagers: see list2
Bulk Api Vendors: see list25
Clinical Trials: see list10
Patent Applications: see list2,519
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:iopamidol at DailyMed

Pharmacology for Ingredient: iopamidol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cook Imaging
IOPAMIDOL-250
iopamidol
INJECTABLE;INJECTION074881-002Jul 28, 2000DISCNNoNo► Subscribe► Subscribe
Abbvie
IOPAMIDOL-300
iopamidol
INJECTABLE;INJECTION074638-001Apr 30, 1997DISCNNoNo► Subscribe► Subscribe
Hospira
IOPAMIDOL
iopamidol
INJECTABLE;INJECTION074734-002Dec 10, 1996DISCNNoNo► Subscribe► Subscribe
Bracco
ISOVUE-370
iopamidol
INJECTABLE;INJECTION020327-004Oct 12, 1994RXYesYes► Subscribe► Subscribe
Bracco
ISOVUE-128
iopamidol
INJECTABLE;INJECTION018735-005Oct 21, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot